Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Chemkart India IPO
Price Band
₹236.0–248.0
Issue Size
₹80.08 Cr
Lot Size
600 shares
Min Investment
₹297,600
2 LOTS MIN
GMP
+₹3.0 (1.21%)
Issue Price
₹248.0
Subject to Sauda
₹1400
Paid only if allotted
Chemkart India IPO AI Summary
- Chemkart India IPO is listed on BSE SME in the Other Food Products sector.
- Price band: ₹236.0–₹248.0 per share, lot size 600 shares (min. investment ₹297,600, 2 lots minimum).
- Subscription window: 07 Jul–09 Jul 2025, listing on 14 Jul 2025.
- Current GMP is +₹3.0 (1.21%), an estimated listing price of ₹251 — unofficial and can change daily.
Chemkart India Limited is set to list on July 14, 2025, following its IPO with a price band of ₹236.0 to ₹248.0. The company has shown significant growth in both revenue and profit over the past few years, supported by its diversified product offerings and operational capabilities.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Chemkart India IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 09 Jul 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Chemkart India IPO Grey Market Premium (GMP) Today
GMP
+₹3.0
GMP %
+1.21%
Est. Listing
₹251.0
Updated: 25 Jul 2026 14:14
About the Company
Incorporated in 2015, Chemkart India Limited is a distributor specializing in high-quality food and health ingredients. The company bridges the gap between global ingredient manufacturers and businesses across various sectors. The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Focused on variety, affordability, quality, and customer relationships, it enhances supply chain processes. The company provides grinding, blending, and packaging services at its hygienic facility in Bhiwandi, Mumbai. The 28,259.16 sq. ft. warehouse is equipped for efficient processing, labeling, and sealing of ingredients. Products Portfolio: Amino Acid: The Building blocks of proteins essential for biological processes and metabolism. Health Supplement: Supplements with essential nutrients and bioactive compounds for wellbeing. Herbal Extract: Extracts from plants used for therapeutic and functional benefits. Nucleotide: Key components supporting immune health, gut health, and nutrition. Protein: Vital for muscle growth, immune function, and overall health. Sports Nutrition: Ingredients supporting athletic performance, endurance, and recovery. Vitamins: Micronutrients essential for various bodily physiological functions. As of March 31, 2025, the company had 40 employees. Competitive Strengths: Diversified product portfolio In house processing and warehousing capabilities Value proposition for Customers
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 86.12 | 53.51 | 37.48 |
| Total Income | 205.46 | 132.83 | 131.69 |
| Profit After Tax | 24.26 | 14.52 | 7.66 |
| EBITDA | 32.76 | 20.91 | 11.05 |
| NET Worth | 53.29 | 29.01 | 14.50 |
| Reserves and Surplus | 43.79 | 27.66 | 13.14 |
| Total Borrowing | 17.03 | 12.55 | 11.33 |
Key Ratios
EPS
₹25.54
NAV
₹56.10
ROE
59%
ROCE
49%
RoNW
45.52%
P/B Value
8.12
P/E Ratio
9.71
Market Cap
₹300.06 Cr
PAT Margin
12.00%
Debt/Equity
0.32
Promoters
Ankit Shailesh Mehta, Parul Shailesh Mehta and Shailesh Vinodrai Mehta
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Pvt.Ltd. 34.68 2 Repayment/prepayment of all or certain of the borrowings availed of by the Company 20.00 3 General Corporate Purposes 0.27 4 Issue Expenses 9.53 Total 64.48
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹131.69 Cr in the year ending 31 Mar 2023, rising to ₹132.83 Cr by 31 Mar 2024, and further increasing to ₹205.46 Cr by 31 Mar 2025. This shows a significant growth in revenue over the periods.
Profit Trend
Profit After Tax was ₹7.66 Cr in the year ending 31 Mar 2023, increasing to ₹14.52 Cr by 31 Mar 2024, and further rising to ₹24.26 Cr by 31 Mar 2025. This indicates a positive trend in profitability over the periods.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO compared to its issue price. A positive GMP suggests that the stock may list at a higher price than the issue price, reflecting investor demand in the grey market.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, risk tolerance, and market conditions.
Who May Want to Wait
Investors who prefer stable and established companies may want to avoid this IPO, as it operates in a growth stage with inherent risks associated with new businesses.
IPO Timeline, Explained
The IPO opens for subscription on July 7, 2025, and closes on July 9, 2025. Allotment of shares will be finalized by July 10, 2025, with the listing date set for July 14, 2025.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when selling shares on the listing day. However, these gains are not guaranteed and can be affected by market conditions, investor sentiment, and overall demand for the stock.
This evaluation is generated from Chemkart India's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Chemkart India IPO GMP today?
Chemkart India IPO GMP today is +₹3.0 (1.21%), indicating an estimated listing price of ₹251. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Chemkart India IPO?
The price band of Chemkart India IPO is ₹236.0–₹248.0 per share.
When does Chemkart India IPO open and close?
Chemkart India IPO opens on 07 July 2025 and closes on 09 July 2025.
When does Chemkart India IPO list on the stock exchange?
Chemkart India IPO listed on 14 July 2025 at ₹251.0.
What is the lot size for Chemkart India IPO?
The lot size for Chemkart India IPO is 600 shares, requiring a minimum investment of ₹297,600 (2 lots).
What is the price band for the Chemkart India IPO?
The price band for the Chemkart India IPO is ₹236.0 to ₹248.0.
What is the minimum investment required?
The minimum investment required is ₹297,600.0.
What is the lot size for this IPO?
The lot size for the Chemkart India IPO is 600 shares.
When is the listing date for the IPO?
The listing date for the IPO is July 14, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO compared to its issue price.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
07 Jul 2025
Close
09 Jul 2025
Allotment
10 Jul 2025
Listing
14 Jul 2025
Similar IPOs in Other Food Products
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Chemkart India?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.